Navigation Links
Quest Diagnostics Finalizes Previously Announced Settlement With Government Related to Test Kit Subsidiary Closed in 2006
Date:4/15/2009

hat patients and doctors need to make better healthcare decisions. The company offers the broadest access to diagnostic testing services through its network of laboratories and patient service centers, and provides interpretive consultation through its extensive medical and scientific staff. Quest Diagnostics is a pioneer in developing innovative diagnostic tests and advanced healthcare information technology solutions that help improve patient care.

The statements in this press release which are not historical facts may be forward-looking statements. Readers are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date that they are made and which reflect management's current estimates, projections, expectations or beliefs and which involve risks and uncertainties that could cause actual results and outcomes to be materially different. Risks and uncertainties that may affect the future results of the company include, but are not limited to, adverse results from pending or future government investigations, lawsuits or private actions, the competitive environment, changes in government regulations, changing relationships with customers, payers, suppliers and strategic partners and other factors discussed in "Business" in Part I, Item 1, "Risk Factors" and "Cautionary Factors that May Affect Future Results" in Part I, Item 1A, "Legal Proceedings" in Part I, Item 3, "Management's Discussion and Analysis of Financial Condition and Results of Operations" in Part II, Item 7 and "Quantitative and Qualitative Disclosures About Market Risk" in Part II, Item 7A in the company's 2008 Annual Report on Form 10-K and other items throughout the Form 10-K and Current Reports on Form 8-K.


'/>"/>
SOURCE Quest Diagnostics Incorporated
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. ImmuneRegen Responds to Defense Threat Reduction Agency Request for Information
2. NovaQuest Advances Virtual Development Model With Strategic Investment in TOPIGEN Pharmaceuticals
3. Quest Diagnostics to Speak at the 2007 UBS Global Life Sciences Conference
4. VioQuest Pharmaceuticals to Present at BIO InvestorForum in San Francisco
5. Quest Diagnostics Joins National ePrescribing Patient Safety Initiative (NEPSI)
6. University HealthSystem Consortium Chooses SciQuest to Optimize Medical Research Procurement
7. VioQuest Pharmaceuticals to Present at the Paramount BioSciences Healthcare Conference
8. Sinovac Requests Extension for Annual Shareholders Meeting
9. Maryland Stem Cell Commission Issues Nationwide Request for Applications for New Post-Doctoral Fellowship Grants
10. AmSurg Selects SciQuest Eprocurement Solution to Automate Purchasing of Medical Goods and Services
11. Quest PharmaTech to Receive $3,000,000 to Develop Oncology Products Based on its SonoLight Technology

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... , Health care employmen...emains the only one to show consistent growth duri...lty hospitals remain in trouble, and health system...cal personnel, instead of just administrators. , ...-- Health care employment continued growing in Oct...
(Date:11/24/2009)... ,, SEATTLE,Nov.24/PRNewswire/--BlueMarbleEn...ublicDevelopmentAuthority(OPDA)wererecentlyawarded...alizationBoard(CERB)inaprivate/publicpartnershipto...ineryinLincolnCounty,WA. ,, "Thisinvestmentwill...dbringover70greenjobstoLincolnCounty,"saidBlueMarb...
(Date:11/24/2009)... ,, SANDIEGO,Nov.24,2009/PRNewswire-FirstCal...ced todaythatthecompanyisscheduledtopresentattheP...r1,2009at11:30a.m.EasternTime(8:30a.m.PacificTime)...a,s President andChiefExecutiveOfficer,isscheduled...aldevelopmentanddiscoveryprograms. ,, Aliveaudi...
(Date:11/24/2009)... ,, SEATTLE,Nov.24/PRNewswire-FirstCall/--Ce...entwillpresentatthe21stAnnualPiperJaffrayHealthCar...9,attheNewYorkPalaceHotel. ,, CTIwillpresentonT...hFloor).AliveaudiowebcastofCTI,spresentationwillbe...obeavailableforreplayafterwards. , ,PiperJaffrayH...
Breaking Biology Technology:The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2
...nsional liquid chromatography (MDLC) • revers...MS/MS • DeCyder MS • differential analys...n conjunction with tandem mass spectrometry (MS/MS...racted from the pollen of the olive tree, Olea eu...oftware (DeCyder MS) was used to quantitate differ...
... DNA Genotek Inc., Ottawa, ON, Canada , ...l with TaqMan SNP Genotyping Assays. , SN...n E genes were reliably , detected., ...nucleotide polymorphisms (SNPs) are highly abundan...of every 1,000 bases in the human genome (ref. 1)....
... Ottawa, Ontario, Canada , , St...n add significant , costs to a project. O..., specimens to be stored for years at room..., , Introduction , L...to thousands of subjects, , are frequentl...
Other Biology Technology:Detection, identification, and quantitation of an olive allergen using Ettan MDLC, MS/MS, and DeCyder MS 2Detection, identification, and quantitation of an olive allergen using Ettan MDLC, MS/MS, and DeCyder MS 3Detection, identification, and quantitation of an olive allergen using Ettan MDLC, MS/MS, and DeCyder MS 4Detection, identification, and quantitation of an olive allergen using Ettan MDLC, MS/MS, and DeCyder MS 5Detection, identification, and quantitation of an olive allergen using Ettan MDLC, MS/MS, and DeCyder MS 6Detection, identification, and quantitation of an olive allergen using Ettan MDLC, MS/MS, and DeCyder MS 7Detection, identification, and quantitation of an olive allergen using Ettan MDLC, MS/MS, and DeCyder MS 8Detection, identification, and quantitation of an olive allergen using Ettan MDLC, MS/MS, and DeCyder MS 9Oragene is compatible with TaqMan SNP genotyping 2Oragene is compatible with TaqMan SNP genotyping 3DNA Stability with Oragene 2DNA Stability with Oragene 3
(Date:11/23/2009)... CHAMPAIGN, Ill. A new study provides "incontrov... of Toba on the island of Sumatra about 73,000 yea...0 miles from the epicenter, researchers report. ,...eters of ash into the atmosphere, leaving a crater...00 kilometers long and 35 kilometers wide. Ash fro...
(Date:11/23/2009)..., BIRMINGHAM, Ala. A new study by University of...t body-mass index (BMI) and co-existing medical co...ed survival observed among African-Americans compa...study is published online Nov. 23 in Cancer , a j...ding indicates that although BMI and co-morbidity ...
(Date:11/23/2009)...CORVALLIS, Ore. A string of recent discoveries ab...renewed interest in this multi-purpose nutrient, i...ho are deficient in it, spurred research and even ...ic." , On issues ranging from the health of your...even vulnerability to influenza, vitamin D is now ...
Breaking Biology News(10 mins):Supervolcano eruption -- in Sumatra -- deforested India 73,000 years ago 2Racial disparity in colon cancer survival not easily explained, UAB researchers say 2Multiple health concerns surface as winter, vitamin D deficiences arrive 2Multiple health concerns surface as winter, vitamin D deficiences arrive 3Diamyd 28R 29 Phase III Study Approved for Younger Patients in the US 12511 1Diamyd 28R 29 Phase III Study Approved for Younger Patients in the US 12511 2Photos 3A FDA Approves 12 Month Labeling Update for EVOLENCE 28R 29 Collagen Based Facial Filler 12508 1Photos 3A FDA Approves 12 Month Labeling Update for EVOLENCE 28R 29 Collagen Based Facial Filler 12508 2Photos 3A FDA Approves 12 Month Labeling Update for EVOLENCE 28R 29 Collagen Based Facial Filler 12508 3Photos 3A FDA Approves 12 Month Labeling Update for EVOLENCE 28R 29 Collagen Based Facial Filler 12508 4Somanetics Corporation to Release Second Quarter 2009 Financial Results and Host Conference Call June 17 2009 48147 1Somanetics Corporation to Release Second Quarter 2009 Financial Results and Host Conference Call June 17 2009 48147 2
...covery that sheds new light upon the growth and de...rful but somewhat mysterious components of the bod...se against cancer and infectious diseases. , Scien...are generated in bone marrow, but Michael Caligiur... and the senior author of the study, says research...
...ntific world has accepted for more than 100 years,...eir grandparents, bypassing genetic abnormalities ...nts apparently have hidden templates containing ge...at can be transferred to their offspring, even tho...rding to Purdue University researchers. This disco...
... severe malaria before they reach hospital, has th... this week,s BMJ. , Every year over a million chi...talities occur outside hospital, especially in rur...lf of deaths occur within 24 hours of admission. ,...t possible to administer outside hospital, so buyi...
Other Biology News:Scientists identify new model Of NK cell development 2Scientists identify new model Of NK cell development 3Plants defy Mendel's inheritance laws, may prompt textbook changes 2Plants defy Mendel's inheritance laws, may prompt textbook changes 3
Yeast-GFP 96-well Plates from Invitrogen
...joined forces with the Mickle Laboratory Engineeri...hopper. This tissue sectioning system has been des...experiments and to be especially applicable to sma...from small organs. Its special features cause much...
Earle's Balanced Salt Solution, 10x (EBSS) from Sigma-Aldrich
...ive peptides are molecules of peptidic nature or o...vity which can be developed at the industrial leve...o-food applications. In this way it is possible to... for therapeutic applications. Primm offers a desi...
Biology Products: